Carl Alden
Biotechnology
BRIM Biotech
Taiwan
Biography
Carl has more than 35 years of pharmaceutical industry toxicology/pathology experience at companies such as Millennium, Searle/Monsanto/Pharmacia, and Procter & Gamble. Carl is a past Editor of Veterinary Pathology (2008-2014) and Toxicologic Pathology (1996-1999) and past President, Society of Toxicologic Pathologists (1990-1991). He was elected as a Distinguished Member of the American College of Veterinary Pathologists in 2011 and presented the Lifetime Achievement Award by the Society of Toxicologic Pathology in 2013. He has played a central role in the development of many drugs such as Celebrex, Velcade and Entyvio (vedolizumab).
Research Interest
Pharmaceutical Sciences
